NEW YORK, Dec. 07, 2025 (GLOBE NEWSWIRE) -- Leading securities law firm Bleichmar Fonti & Auld LLP announces that a class action lawsuit has been filed against Alexandria Real Estate Equities, Inc. (NYSE: ARE) and certain of the Company's senior executives for securities fraud after a significant stock drop resulting from the potential violations of the federal securities laws. If you invested in Alexandria Real Estate, you are encouraged to obtain additional information by visiting: https://www.bfalaw.com/cases/alexandria-real-estate-class-action-lawsuit.
ARE
globenewswire.com
• Dec. 7, 2025
NEW YORK, Dec. 07, 2025 (GLOBE NEWSWIRE) -- Leading securities law firm Bleichmar Fonti & Auld LLP announces that a class action lawsuit has been filed against CarMax, Inc. (NYSE: KMX) and certain of the Company's senior executives for securities fraud after a significant stock drop resulting from the potential violations of the federal securities laws. If you invested in CarMax, you are encouraged to obtain additional information by visiting: https://www.bfalaw.com/cases/carmax-inc-class-action-lawsuit.
KMX
globenewswire.com
• Dec. 7, 2025
NEW YORK, Dec. 07, 2025 (GLOBE NEWSWIRE) -- Leading securities law firm Bleichmar Fonti & Auld LLP announces that a class action lawsuit has been filed against Inspire Medical Systems, Inc. (NYSE: INSP) and certain of the Company's senior executives for securities fraud after a significant stock drop resulting from the potential violations of the federal securities laws. If you invested in Inspire, you are encouraged to obtain additional information by visiting: https://www.bfalaw.com/cases/inspire-medical-systems-inc-class-action-lawsuit.
INSP
globenewswire.com
• Dec. 7, 2025
NEW YORK, Dec. 07, 2025 (GLOBE NEWSWIRE) -- Leading securities law firm Bleichmar Fonti & Auld LLP announces that a class action lawsuit has been filed against Freeport-McMoRan Inc. (NYSE: FCX) and certain of the Company's senior executives for securities fraud after significant stock drops resulting from the potential violations of the federal securities laws. If you invested in Freeport, you are encouraged to obtain additional information by visiting: https://www.bfalaw.com/cases/freeport-mcmoran-inc-class-action-lawsuit.
FCX
globenewswire.com
• Dec. 7, 2025
NEW YORK, Dec. 07, 2025 (GLOBE NEWSWIRE) -- Leading securities law firm Bleichmar Fonti & Auld LLP announces an investigation into Jefferies Financial Group Inc. (NYSE: JEF) and Point Bonita Capital for potential violations of the federal securities laws after SEC probe is revealed. If you invested in Jefferies or Point Bonita, you are encouraged to obtain additional information by visiting: https://www.bfalaw.com/cases/jefferies-financial-group-inc-class-action.
JEF
globenewswire.com
• Dec. 7, 2025
NEW YORK, Dec. 07, 2025 (GLOBE NEWSWIRE) -- Leading securities law firm Bleichmar Fonti & Auld LLP announces that a class action lawsuit has been filed against Synopsys, Inc. (NASDAQ: SNPS) and certain of the Company's senior executives for securities fraud after a significant stock drop resulting from the potential violations of the federal securities laws. If you invested in Synopsys, you are encouraged to obtain additional information by visiting: https://www.bfalaw.com/cases/synopsys-inc-class-action-lawsuit.
SNPS
globenewswire.com
• Dec. 7, 2025
NEW YORK, Dec. 07, 2025 (GLOBE NEWSWIRE) -- Leading securities law firm Bleichmar Fonti & Auld LLP announces that a lawsuit has been filed against MoonLake Immunotherapeutics (NASDAQ: MLTX) and certain of the Company's senior executives for potential violations of the federal securities laws. If you invested in MoonLake, you are encouraged to obtain additional information by visiting: https://www.bfalaw.com/cases/moonlake-immunotherapeutics-class-action-lawsuit.
MLTX
globenewswire.com
• Dec. 7, 2025
NEW YORK, Dec. 07, 2025 (GLOBE NEWSWIRE) -- Leading securities law firm Bleichmar Fonti & Auld LLP announces that a class action lawsuit has been filed against Stride, Inc. (NYSE: LRN) and certain of the Company's senior executives for securities fraud after significant stock drops resulting from the potential violations of the federal securities laws. If you invested in Stride, you are encouraged to obtain additional information by visiting: https://www.bfalaw.com/cases/stride-inc-class-action-lawsuit.
LRN
globenewswire.com
• Dec. 7, 2025
NEW YORK, Dec. 07, 2025 (GLOBE NEWSWIRE) -- Leading securities law firm Bleichmar Fonti & Auld LLP announces that a class action lawsuit has been filed against James Hardie Industries plc (NYSE: JHX) and certain of the Company's senior executives for securities fraud after a significant stock drop resulting from the potential violations of the federal securities laws. If you invested in James Hardie, you are encouraged to obtain additional information by visiting: https://www.bfalaw.com/cases/james-hardie-industries-class-action-lawsuit.
JHX
globenewswire.com
• Dec. 7, 2025
ZURICH-SCHLIEREN, Switzerland and CONCORD, Mass., Dec. 07, 2025 (GLOBE NEWSWIRE) -- Ad hoc announcement pursuant to Art. 53 LR Molecular Partners AG (SIX: MOLN; NASDAQ: MOLN), a clinical-stage biotech company developing a new class of custom-built protein drugs known as DARPin therapeutics (“Molecular Partners” or the “Company”), has today announced it will present updated data from a Phase 1/2a trial of the multispecific T-cell engager MP0533 in patients with acute myeloid leukemia (AML) in a poster at the 67th American Society of Hematology (ASH) Annual Meeting and Exposition, taking place December 6-9, 2025, in Orlando, Florida.
PGPHF
globenewswire.com
• Dec. 7, 2025
Carvana (NYSE: CVNA) shares are soaring following a major catalyst that has thrust the online used-car retailer back into Wall Street's spotlight.
CVNA
finbold.com
• Dec. 7, 2025
TSM remains a compelling buy at current heights, underpinned by the near-monopolistic foundry market share at 71%, the promising FQ4'25 guidance, and the upcoming multi-year price hikes. This is significantly aided by the growing demand for its advanced CoWoS packaging capabilities during the ongoing cloud/AI supercycle. These underscore TSM's strong pricing power, arising from its ability to efficiently deliver cutting-edge chip technologies at higher yields, which explains its increasingly rich gross/operating margins.
TSM
seekingalpha.com
• Dec. 7, 2025
AeroVironment is uniquely positioned in the rapidly evolving defense-tech sector, benefiting from surging global demand for drones and remote warfare solutions. I maintain a strong buy rating on AVAV, citing robust contract momentum, a growing $1.1 billion backlog, and favorable structural tailwinds from U.S. and NATO initiatives. AVAV's margin volatility is transitional, with management guiding for steady improvement toward 35% by Q4 and long-term rerating potential as integration stabilizes.
AVAV
seekingalpha.com
• Dec. 7, 2025
Credo's stock has soared nearly 1,700% from its initial public offering. The rapid growth of the AI market is lighting a fire under its business.
CRDO
fool.com
• Dec. 7, 2025
QDVO is categorized as a “Three-in-One ETF” and aims to provide appreciation, competitive dividends, and an options strategy. This sets it apart from the rest of the covered call ETFs, which instead focus mainly on overlaying the underlying assets with options. Its holding distribution makes it, in my opinion, suitable for a moderately bullish scenario.
QDVO
seekingalpha.com
• Dec. 7, 2025
Arcellx, Inc. (ACLX) Discusses Phase 2 iMMagine-1 Study Results and Multiple Myeloma Treatment Advances Transcript
ACLX
seekingalpha.com
• Dec. 7, 2025
Doximity's Q2 results show record engagement and accelerating adoption of AI workflow tools, signaling deeper physician reliance on the platform. Revenue quality is improving as pharma clients shift from one-off ad buys to longer-term integrated programs. Doximity has a strong Rule-of-50 profile with high margins and $890m cash but no debt.
DOCS
seekingalpha.com
• Dec. 7, 2025
SoFi stands out from other digital banks in many ways, targeting a younger audience and offering a one-stop shop of online services. It sees huge growth opportunities in cross-selling products to its young users.
SOFI
fool.com
• Dec. 7, 2025
UP Fintech is accelerating its transformation into a multilayer fintech platform, with robust revenue and margin expansion. Q3 revenue surged 73% YoY and 26% QoQ, driven by organic growth across trading, interest, IPO underwriting, and wealth management. Non-GAAP net income reached $57 million, with margins expanding to nearly 33%, outpacing sector norms and reflecting disciplined cost control.
TIGR
seekingalpha.com
• Dec. 7, 2025
AI companies want to put AI data centers in space. Rocket Lab has the rockets that could help do just that.
RKLB
fool.com
• Dec. 7, 2025
